SciSparc SPRC Stock
SciSparc Price Chart
SciSparc SPRC Financial and Trading Overview
| SciSparc stock price | 4.72 USD |
| Previous Close | 4.55 USD |
| Open | 4.57 USD |
| Bid | 3.24 USD x 200 |
| Ask | 6.01 USD x 200 |
| Day's Range | 4.57 - 4.9 USD |
| 52 Week Range | 2.98 - 43.74 USD |
| Volume | 2.76K USD |
| Avg. Volume | 181.02K USD |
| Market Cap | 108.91M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.019013856 |
| EPS (TTM) | 248.24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SPRC Valuation Measures
| Enterprise Value | 8.18M USD |
| Trailing P/E | 0.019013856 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 95.53132 |
| Price/Book (mrq) | 0.40689653 |
| Enterprise Value/Revenue | 7.178 |
| Enterprise Value/EBITDA | -0.652 |
Trading Information
SciSparc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -88.49% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 43.74 USD |
| 52 Week Low | 2.98 USD |
| 50-Day Moving Average | 5.9 USD |
| 200-Day Moving Average | 6.63 USD |
SPRC Share Statistics
| Avg. Volume (3 month) | 181.02K USD |
| Avg. Daily Volume (10-Days) | 25.84K USD |
| Shares Outstanding | 23.07M |
| Float | 534.79K |
| Short Ratio | 0.28 |
| % Held by Insiders | 0% |
| % Held by Institutions | 9.25% |
| Shares Short | 10.99K |
| Short % of Float | 1.89% |
| Short % of Shares Outstanding | 1.89% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1720.77% |
| Gross Margin | 73.94% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.93% |
| Return on Equity (ttm) | -315.62% |
Income Statement
| Revenue (ttm) | 1.14M USD |
| Revenue Per Share (ttm) | 3.06 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 843K USD |
| EBITDA | -12558000 USD |
| Net Income Avi to Common (ttm) | -16594000 USD |
| Diluted EPS (ttm) | 248.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.44M USD |
| Total Cash Per Share (mrq) | 8.01 USD |
| Total Debt (mrq) | 2.68M USD |
| Total Debt/Equity (mrq) | 23.77 USD |
| Current Ratio (mrq) | 0.873 |
| Book Value Per Share (mrq) | 11.6 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5837000 USD |
| Levered Free Cash Flow (ttm) | -6780125 USD |
Profile of SciSparc
| Country | United States |
| State | N/A |
| City | Tel Aviv-Yafo |
| Address | Tower A |
| ZIP | 6971916 |
| Phone | 972 7 334 47180 |
| Website | https://scisparc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Q&A For SciSparc Stock
What is a current SPRC stock price?
SciSparc SPRC stock price today per share is 4.72 USD.
How to purchase SciSparc stock?
You can buy SPRC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SciSparc?
The stock symbol or ticker of SciSparc is SPRC.
Which industry does the SciSparc company belong to?
The SciSparc industry is Biotechnology.
How many shares does SciSparc have in circulation?
The max supply of SciSparc shares is 23.07M.
What is SciSparc Price to Earnings Ratio (PE Ratio)?
SciSparc PE Ratio is 0.01901386 now.
What was SciSparc earnings per share over the trailing 12 months (TTM)?
SciSparc EPS is 248.24 USD over the trailing 12 months.
Which sector does the SciSparc company belong to?
The SciSparc sector is Healthcare.
SciSparc SPRC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
